CSI Market
Sign In | Register

Concert Pharmaceuticals Inc (CNCE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CNCE Annual Cash Flow →
The table below presents a historical view of Concert Pharmaceuticals Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-90.18
Depreciation & amortization0.94
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation5.97
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Amortization Of Deferred Lease Incentives-
Noncash Revenue Recognized-
Equity Securities Fv Ni Unrealized Gain Loss0.79
Lease Expense Operating Activities Noncash Expense0.38
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Contract With Customer Liability-
Capital Expenditures Incurred But Not Yet Paid0.01
Public Offering Costs Incurred But Not Yet Paid-
Operating Lease Liability Increase Decrease-0.85
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-1.43
Increase (Decrease) in Accounts Payable0.14
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.92
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.86
Discontinued operations0.00
Net Cash flow from Operating Activities-83.19
Investing Activities
Capital Expenditures-0.27
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities49.50
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-103.35
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-54.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock90.85
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Repayments Of Leasehold Improvement Loan-
Proceeds From Common Stock And Pre Funded Warrants Sold Net Of Underwriters Discount And Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities90.85
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-83.45
Total Cash Flow-46.45
4 historic quarters locked

Sign in to unlock the full Concert Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Concert Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001367920-22-000075

Figures are derived from filed reports and may be restated. Historical data is subject to revision.